메뉴 건너뛰기




Volumn 9, Issue 9, 2018, Pages 1439-1456

β-lactam/β-lactamase inhibitor combinations: an update

Author keywords

[No Author keywords available]

Indexed keywords

AAI 101; AVIBACTAM; AVIBACTAM PLUS CEFTAZIDIME; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; BORONIC ACID DERIVATIVE; CEFEPIME; CEFTAROLINE FOSAMIL; CEFTAZIDIME; CEFTOLOZANE PLUS TAZOBACTAM; CILASTATIN PLUS IMIPENEM; CLAVULANIC ACID; ETX 2514; MEROPENEM; MEROPENEM PLUS VABORBACTAM; NACUBACTAM; RELEBACTAM; SULBACTAM; TAZOBACTAM; UNCLASSIFIED DRUG; VABORBACTAM; VALBOMERE; ZIDEBACTAM;

EID: 85053861703     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c8md00342d     Document Type: Review
Times cited : (114)

References (191)
  • 29
    • 85053900793 scopus 로고    scopus 로고
    • Vabomere product sheet, http://www.vabomere.com/media/pdf/P-VAB-US-00050_R01_MVAB_HCP_OrderSheet_Web.pdf
    • Vabomere product sheet
  • 58
    • 84954364353 scopus 로고    scopus 로고
    • L. J. Scott Drugs 2016 76 231-242
    • (2016) Drugs , vol.76 , pp. 231-242
    • Scott, L.J.1
  • 70
    • 85053940668 scopus 로고    scopus 로고
    • Zerbaxa webpage, https://www.merckconnect.com/zerbaxa/about-zerbaxa.html
    • Zerbaxa webpage


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.